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(PTA) or thromboendarterectomy (TEA) and 1 bypass
infection) versus 15 patients (32%) with bypass related
complications in the IAOD group (4 bypass infections, 2
wound infections, 8 stenoses or occlusions requiring PTA/
TEA (n7) or removal (n1) and 1 ischemic leg) (P 
.05).
Conclusions: Femorofemoral bypasses have compara-
ble patency rates for aneurysmal and occlusive disease.
However, bypass related complications are more often seen
in IAOD patients.
Author Disclosures: J. P. de Vries: Nothing to disclose;
E. D. Kaan: Nothing to disclose; F. L. Moll: Nothing to
disclose; J. A. van Herwaarden: Nothing to disclose;H. J.
Zandvoort: Nothing to disclose.
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Objectives:The retrogeniculate popliteal artery (RGP)
is conventionally regarded as unsuitable for stenting due to
a perceived risk of accelerated restenosis and fracture. This
study sought to evaluate the efficacy of angioplasty (PTA)
alone compared to PTA and stenting in management of
atherosclerotic disease of the RGP.
Methods: Patients who underwent RGP angioplasty
with or without stenting were drawn from a prospectively-
maintained database of patients undergoing lower extrem-
ity intervention. Disease characteristics were obtained from
angiogram and chart review. Primary and secondary paten-
cies as well as limb salvage were calculated using Kaplan-
Meier analysis.
Results: From 2004-2011, 74 isolated RGP lesions
were identified that were primarily treated with PTA. Mean
follow-up was 15.815 months. TASC B, C, and D clas-
sification was 51, 33, and 16% respectively. Procedural
success (30% residual stenosis) was 57% with angioplasty
alone. Overall, 47 lesions were treated with PTA alone and
27 required adjunctive stenting. No significant differences
were found between PTA and PTAS at any time point for
primary, primary assisted, or secondary patencies or for
rates of limb salvage.
Conclusions: The retrogeniculate popliteal artery has
historically been considered a poor location for stent place-
ment in the treatment of atherosclerotic occlusive disease
because of a perceived high risk of complication and accel-
erated restenosis. We show, however, that stent placement
in this location confers no decrease in patency or limb
salvage compared to angioplasty alone.
Author Disclosures: F. Aiello: Nothing to disclose; P. H.
Connolly: Nothing to disclose; N. Kabutey: Nothing to
disclose; J. Karwowski: Nothing to disclose; R. Kundi:
Nothing to disclose; A. J. Meltzer: Nothing to disclose.
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Major Limb Amputation Is Higher in Regions with
Limited Access to Cardiovascular Specialists
Katharine L. McGinigle1, Peter J. Leese3, Thomas C. Rick-
etts2, William A. Marston1. 1Department of Surgery, Uni-
versity of North Carolina, ChapelHill, NC; 2Cecil G. Sheps
Center for Health Services Research, University of North
Carolina, Chapel Hill, NC; 3Department of Performance
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Objectives: To analyze the rate of major limb amputa-
tions in North Carolina in relation to physician density and
comorbidities including diabetes (DM), end stage renal
disease (ESRD), peripheral vascular disease (PVD), and
lower extremity ulcers.
Methods: Using the NC Hospital Inpatient Discharge
Database, the rate of hospital discharges with DM, ESRD,
PVD, lower extremity ulcer, or major amputation from
2006-2009 was calculated. The NC Health Professions
Data System was used to define cardiovascular specialist
(CVS; surgeons, cardiologists, nephrologists, radiologists)
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